The U.S. Judicial Panel on Multidistrict Litigation recently agreed to consolidate all pending federal fluoroquinolone lawsuits into a multidistrict litigation. The initial order named 20 lawsuits in 15 districts to be transferred to the U.S. District Court for the Southern District of Minnesota.
Fluoroquinolones are a group of wide-spectrum antibiotics generally used to treat respiratory and urinary infections. The U.S. Food and Drug Administration (FDA) requested in 2008 that manufacturers ...
continue reading...